Skip to main content

Table 2 Outcomes of patients with MRSA pneumonia and patients with non-MRSA pneumonia after 1:4 matching

From: In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study

 

MRSA pneumonia

Non-MRSA pneumonia

p-value

In-hospital mortality

967

(31.2)

1429

(11.6)

 < 0.001

30-day mortality

382

(12.3)

1011

(8.20)

 < 0.001

90-day mortality

809

(26.1)

1330

(10.8)

 < 0.001

Length of stay (days)

35.0

[22–62]

14.0

[9–23]

 < 0.001

Antibiotic therapy (days)

24.0

[15–45]

9.0

[6–13]

 < 0.001

Hospitalisation costs (USD)

12,156

[7827–20,615]

4665

[3163–7298]

 < 0.001

  1. Data are expressed as numbers (%) or as medians [interquartile ranges]
  2. MRSA, methicillin-resistant Staphylococcus aureus; USD, United States Dollar
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us